Report Library
All Reports.jpg)
JP Morgan 2019 - Day 1
January 07, 2019
The 37th annual JP Morgan Healthcare Conference is being held in San Francisco, CA from January 7-10, 2019. A list of events and
catalysts that were announced or updated at the conference today is included in this report.
Highlights from today’s company presentations are included for:
Mega Cap
For our disclosures, please read the Biomedtracker Research Standards.
Highlights from today’s company presentations are included for:
Mega Cap
- Novartis (NVS)
- Pfizer (PFE)
- Merck KGaA (MKGAY)
- Celgene (CELG)
- Allergan (AGN)
- Biogen (BIIB)
- BioMarin(BMRN)
- Bristol Myers (BMY)
- Daiichi Sankyo (4568.T)
- Dexcom (DXCM)
- Gilead (GILD)
- Incyte (INCY)
- Jazz (JAZZ)
- Medtronic (MDT)
- Regeneron (REGN)
- Teva Pharmaceuticals (TEVA)
- Vertex (VRTX)
- Acceleron (XLRN)
- Alnylam (ALNY)
- Array (ARRY)
- Santen (SZD.F)
- Sarepta (SRPT)
- Seattle Genetics (SGEN)
- United Therapeutics (UTHR)
- Karyopharm (KPTI)
- Mallinckrodt (MNK)
- MyoKardia (MYOK)
- Rubius Therapeutics (RUBY)
- Springworks
For our disclosures, please read the Biomedtracker Research Standards.
| Disease Group Covered: |
Allergy
Autoimmune/immunology Cardiovascular Dermatology Endocrine ENT/Dental Gastroenterology (Non Inflammatory Bowel Disease) Hematology Infectious Disease Metabolic Neurology Not Specified Obstetrics/Gynecology Oncology Ophthalmology Orthopedics Psychiatry Renal Respiratory Rheumatology (Non Autoimmune) Urology |
Additional Resources:
- 2019 JP Morgan Conference Preview
- Datamonitor Healthcare HR+/HER2- Breast Cancer KOL Interview – US, West Coast
- Datamonitor Healthcare HR+/HER2- Breast Cancer KOL Interview – US, Midwest
- Datamonitor Healthcare HR+/HER2- Breast Cancer KOL Interview – UK
- Datamonitor Healthcare CNS: Migraine Disease Coverage